LBMC Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.08M Buy
8,999
+59
+0.7% +$6.81K 0.07% 103
2025
Q4
$941K Sell
8,940
-120
-1% -$11.3K 0.06% 107
2025
Q3
$760K Buy
9,060
+274
+3% +$22.6K 0.05% 116
2025
Q2
$696K Hold
8,786
0.05% 106
2025
Q1
$789K Hold
8,786
0.06% 92
2024
Q4
$874K Sell
8,786
-100
-1% -$10.3K 0.07% 83
2024
Q3
$1.01M Hold
8,886
0.08% 74
2024
Q2
$1.1M Hold
8,886
0.1% 69
2024
Q1
$1.17M Sell
8,886
-120
-1% -$14.8K 0.1% 68
2023
Q4
$982K Buy
9,006
+180
+2% +$18.7K 0.09% 60
2023
Q3
$898K Buy
8,826
+75
+0.9% +$8.08K 0.1% 61
2023
Q2
$1.01M Hold
8,751
0.1% 58
2023
Q1
$931K Hold
8,751
0.09% 62
2022
Q4
$971K Sell
8,751
-132
-1% -$13.5K 0.1% 58
2022
Q3
$765K Sell
8,883
-104
-1% -$9.28K 0.09% 60
2022
Q2
$819K Sell
8,987
-12
-0.1% -$1.06K 0.09% 57
2022
Q1
$738K Sell
8,999
-80
-0.9% -$6.31K 0.07% 72
2021
Q4
$696K Buy
9,079
+6,815
+301% +$543K 0.06% 78
2021
Q3
$682 Sell
2,264
-6,815
-75% -$518K 0.06% 77
2021
Q2
$706K Buy
9,079
+3,547
+64% +$264K 0.07% 74
2021
Q1
$407K Hold
5,532
0.04% 89
2020
Q4
$432K Sell
5,532
-315
-5% -$24.1K 0.05% 79
2020
Q3
$463K Hold
5,847
0.06% 69
2020
Q2
$431K Hold
5,847
0.07% 64
2020
Q1
$429K Buy
5,847
+105
+2% +$8.25K 0.08% 57
2019
Q4
$498K Sell
5,742
-73
-1% -$6K 0.07% 56
2019
Q3
$467K Hold
5,815
0.07% 55
2019
Q2
$465K Buy
5,815
+253
+5% +$19.4K 0.07% 58
2019
Q1
$441K Sell
5,562
-122
-2% -$9.13K 0.07% 56
2018
Q4
$414K Buy
5,684
+122
+2% +$8.61K 0.08% 58
2018
Q3
$376K Sell
5,562
-8
-0.1% -$510 0.06% 70
2018
Q2
$323K Buy
5,570
+8
+0.1% +$451 0.05% 76
2018
Q1
$289K Sell
5,562
-386
-6% -$20.8K 0.05% 70
2017
Q4
$319K Buy
5,948
+1,477
+33% +$81.9K 0.05% 67
2017
Q3
$273K Buy
4,471
+586
+15% +$35.5K 0.05% 67
2017
Q2
$238K Hold
3,885
0.04% 69
2017
Q1
$236K Hold
3,885
0.04% 71
2016
Q4
$218K Sell
3,885
-24
-0.6% -$1.41K 0.04% 70
2016
Q3
$233K Buy
3,909
+24
+0.6% +$1.4K 0.04% 69
2016
Q2
$214K Buy
+3,885
New +$207K 0.04% 65

Other funds holding MRK

LBMC Investment Advisors's MRK Position: Q1 2026 in Review

LBMC Investment Advisors increased its Merck (MRK) stake by 0.66% in Q1 2026, buying an estimated $6.81K and bringing the position to 8,999 shares worth $1.08M. The position accounts for 0.07% of the portfolio, ranked #103.

LBMC Investment Advisors first reported a position in MRK in Q2 2016 and has held it in 40 quarters since. The position peaked at $1.17M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • LBMC Investment Advisors held 8,999 shares of Merck worth $1.08M as of Q1 2026.
  • LBMC Investment Advisors bought 59 Merck shares in Q1 2026, an estimated $6.81K.
  • Merck made up 0.07% of LBMC Investment Advisors's portfolio in Q1 2026, its #103 holding.
  • LBMC Investment Advisors first reported a position in Merck in Q2 2016 and has held it in 40 quarters since.
  • LBMC Investment Advisors's Merck position peaked at $1.17M in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on LBMC Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.